ALLHAT and calcium channel blockers. ALLHAT Research Group.
作者信息
Proschan M, Davis B, Cutler J, Ford C, Furberg C, Grimm R, Oparil S
出版信息
Am J Hypertens. 1997 Jan;10(1):142-3.
PMID:9008261
Abstract
摘要
相似文献
1
ALLHAT and calcium channel blockers. ALLHAT Research Group.抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）与钙通道阻滞剂。ALLHAT研究小组。
Am J Hypertens. 1997 Jan;10(1):142-3.
2
[Long-term treatment with calcium antagonists: advantageous effects and risks].[钙拮抗剂的长期治疗：有益作用和风险]
Ned Tijdschr Geneeskd. 1995 Dec 30;139(52):2715-21.
3
Do calcium channel blockers increase the risk of myocardial infarction in hypertensive patients with diabetes mellitus?钙通道阻滞剂会增加糖尿病高血压患者心肌梗死的风险吗？
Can Fam Physician. 1998 Nov;44:2405-7.
4
Calcium chanel blockers safe, says UMC hypertension expert.大学医学中心高血压专家称钙通道阻滞剂安全。
J Miss State Med Assoc. 1995 May;36(5):154.
5
[Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].[老一代还是新一代抗高血压药物？抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）的结果]
Dtsch Med Wochenschr. 2003 Jan 31;128(5):214-6. doi: 10.1055/s-2003-36980.
6
Calcium channel blockers in the management of hypertension.钙通道阻滞剂在高血压治疗中的应用
Ir Med J. 1996 Jan-Feb;89(1):8.
7
Calcium channel blockers and myocardial infarction.
J Fam Pract. 1996 Jan;42(1):30-2.
8
Nisoldipine and myocardial infarction.尼索地平与心肌梗死
N Engl J Med. 1998 Jul 9;339(2):126; author reply 127.
9
From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists.
J La State Med Soc. 1995 Aug;147(8):343.
10
The safety of calcium-channel blockers.
Clin Cardiol. 1998 Dec;21(12 Suppl 2):II12-7.
Zotero 插件